Sanofi Competitors and Similar CompaniesClear all
Sanofi's competitors and similar companies include Viatris, AbbVie and Teva Pharmaceuticals.
 Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. | ||
Founding Date | Founding Date 1994 | Founding Date 2020 | Founding Date 2013 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more |
Employees | Employees 82,878 | Employees 38,0003% increase | Employees 55,00010% increase | Employees 37,000 |
Valuation ($) | Valuation ($) 141.1 b | Valuation ($) 14 b | Valuation ($) 335 b | Valuation ($) 20.8 b |
Financial | ||||
Revenue (est.) | Revenue (est.) €45.4b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $61.2b (FY, 2025) | Revenue (est.) $17.3b (FY, 2025) |
Cost of goods | Cost of goods €11.6b (FY, 2025) | Cost of goods $9.3b (FY, 2025) | Cost of goods $18.2b (FY, 2025) | Cost of goods $8.3b (FY, 2025) |
Gross profit | Gross profit €37.6b (FY, 2025) | Gross profit $5b (FY, 2025) | Gross profit $43b (FY, 2025) | Gross profit $8.9b (FY, 2025) |
Net income | Net income €8b (FY, 2025) | Net income ($3.5b) (FY, 2025) | Net income $4.2b (FY, 2025) | Net income $1.4b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 165 (Q1, 2023) | Countries 70 (FY, 2022) | Countries N/A |
Product Categories | Product Categories N/A | Product Categories 3 (Q1, 2023) | Product Categories 6 (FY, 2022) | Product Categories N/A |
Funding | ||||
Total funding raised | Total funding raised $ 310m | Total funding raised N/A | Total funding raised $ 3.8b | Total funding raised $ 358m |
For sources of this data, please see the company profile
View Company Profiles
Viatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View companyAbbVie
HQ
North Chicago, US
Employees
55,000↑ 10% increase
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000
Teva Pharmaceuticals is a global pharmaceutical company.
View company